The effects of alcohol and drug abuse on the skin

Clinics in Dermatology

Volumn 28, Issue 4, 2010, Pages 391-399

  Liu, Stephanie W ^a   Lien, Mary H ^a   Fenske, Neil Alan ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABIS; COCAINE; METHAMPHETAMINE;

ALCOHOL ABUSE; ARTICLE; BREAST CARCINOMA; CLINICAL FEATURE; DENTAL CARIES; DISEASE PREDISPOSITION; DRUG ABUSE; EARLY DIAGNOSIS; ERYTHEMA; HOT FLUSH; HUMAN; HYPERPIGMENTATION; JAUNDICE; LIVER CARCINOMA; MOUTH DISEASE; NUTRITIONAL DEFICIENCY; OROPHARYNX CARCINOMA; PANCREAS CARCINOMA; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; PRURITUS; PSORIASIS; RECURRENT INFECTION; SKIN CARCINOMA; SKIN DISEASE; SKIN GRANULOMA; SKIN ULCER; SPIDER VEIN; URTICARIA; ADDICTION; ALCOHOLISM; COMPLICATION; DRUG EFFECTS; FEMALE; MALE; PATHOLOGY; RISK FACTOR; SKIN; SKIN DISEASES;

ALCOHOLISM; FEMALE; HUMANS; MALE; RISK FACTORS; SKIN; SKIN DISEASES; SUBSTANCE-RELATED DISORDERS;

EID: 77953999474     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2010.03.024     Document Type: Article

References (89)

1. American Psychiatric Association Substance-related disorders. American Psychiatric Association: DSM-IV, diagnostic and statistical manual of mental disorders 1994, 191-296. American Psychiatric Association (APA), Washington, DC. 4th ed.
2. Crum R.M. The epidemiology of substance abuse. Principles of addiction medicine 2009, 13-26. Lippincott Williams & Wilkins, Philadelphia. 4th ed. R.K. Ries, S.C. Miller, D.A. Fiellin (Eds.).
3. Mokdad A.H., Marks J.S., Stroup D.F., et al. Actual causes of death in the United States, 2000. JAMA 2004, 29110:1238-1245.
4. Allen N.E., Beral V., Casabonne D., et al. Moderate alcohol intake and cancer incidence in women. J Natl. Cancer Inst 2009, 1015:296-305.
5. Lands W.E. A review of alcohol clearance in humans. Alcohol 1998, 15:147-160.
6. Goodsell D.S. The molecular perspective: alcohol. Oncologist 2006, 11:1045-1046.
7. Rosset M., Oki G. Skin diseases in alcoholics. Q J Stud Alcohol 1971, 32:1017-1022.
8. Foutch P., Sullivan J., Gaines J. Cutaneous vascular spiders in cirrhotic patients: correlation with hemorrhage from esophageal varices. Am J Gastroenterol 1988, 83:723-726.
9. Malpas S., Robinson B., Maling T. Mechanism of ethanol-induced vasodilation. Physiol 1990, 68:731-734.
10. Sarkany L. The skin-liver connection. Clin Exp Dermatol 1988, 13:152-159.
11. Umulis D.M., Gurmen N.M., Singh P., et al. A physiologically based model for ethanol and acetylaldehyde metabolism in human beings. Alcohol 2005, 35:3-12.
12. Bean W. The arterial spider and similar lesions of the skin and mucous membrane. Circulation 1953, 8:117-129.
13. Roche S.P., Kobos R. Jaundice in the adult patient. Am Fam Physician 2004, 69:299-304.
14. Sakarny I., Graham-Brown R.A. Cutaneous manifestations of gastrointestinal and renal disorders. Dermatology in general medicine 1993, 2029-2045. McGraw-Hill, New York. 4th ed. T.B. Fitzpatrick, A.Z. Eisen, K. Wolff (Eds.).
15. Bergasa N.V., Mehlman J.K., Jones E.A. Pruritus and fatigue in primary biliary cirrhosis. Best Pract Res Clin Gastroenterol 2000, 14:643-655.
16. Pusl T., Beuers U. Ursodeoxycholic acid treatment of vanishing bile duct syndromes. World J Gastroenterol 2006, 12:3487-3495.
17. Kremer A., Beuers U., Oude-Elferink R., et al. Pathogenesis and treatment of pruritus in cholestasis. Drugs 2008, 68:2163-2182.
18. Datta D.V., Sherlock S. Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis. Gastroenterology 1966, 50:323-332.
19. Duncan J.S., Kennedy H.J., Triger D.R. Treatment of pruritus due to chronic obstructive liver disease. BMJ (Clin Res Ed) 1984, 289:22. [letter].
20. Di Padova C., Tritapepe R., Rovagnati P., et al. Double-blind placebo-controlled clinical trial of microporous cholestyramine in the treatment of intra- and extra-hepatic cholestasis: relationship between itching and serum bile acids. Methods Find Exp Clin Pharmacol 1984, 6:773-776.
21. Ghent C.N., Carruthers S.G. Treatment of pruritus in primary biliary cirrhosis with rifampin: results of a double-blind, crossover, randomized trial. Gastroenterology 1988, 94:488-493.
22. Garden J., Ostrow J., Roenigk H. Pruritus in hepatic cholestasis. Arch Dermatol 1985, 121:1415-1419.
23. Mills P., Skerrow C., MacKie R. Melanin pigmentation of the skin in primary biliary cirrhosis. J Cutan Pathol 1982, 8:404-410.
24. Sanchez M. Alcohol, social behavior disorders, and their cutaneous manifestations. Clin Dermatol 1999, 17:479-489.
25. Nakagawa Y., Sumikawa Y., Nakamura T., et al. Urticarial reaction caused by ethanol. Allergol Int 2006, 55:411-414.
26. Cou S., Grant B., Dawson D. Medical consequences of alcohol consumption. Alcohol Clin Exp Res 1996, 20:1423-1428.
27. Graham S., Dayal H., Rohrer T., et al. Dentition, diet, tobacco, and alcohol in the epidemiology of oral cancer. J Natl Cancer Inst 1977, 59:1611-1615.
28. Wynder E., Mushinski M., Spivak J. Tobacco and alcohol consumption in relation to the development of multiple primary cancers. Cancer 1977, 40:1872-1878.
29. Oram Y., Orengo I., Griego R., et al. Histologic patterns of basal cell carcinoma based upon patient immunostatus. Dermatol Surg 1995, 21:611-614.
30. Kirkpatrick C.S., White E., Lee J.A. Case control study of malignant melanoma in Washington State. II. Diet, alcohol, and obesity. Am J Epidemiol 1994, 139:869-880.
31. Woeber K. The skin in diagnosis of alcoholism. Ann N Y Acad Sci 1975, 252:292-295.
32. Larato D. Oral tissue changes in the chronic alcoholic. J Peridontal 1972, 43:772-773.
33. Lieber C.S. Relationships between nutrition, alcohol use, and liver disease. Alcohol Res Health 2003, 27:220-231.
34. Miller S. Nutritional deficiency and the skin. J Am Acad Dermatol 1989, 21:1-30.
35. Hendricks W. Pellagra and pellagra-like dermatoses: etiology, differential diagnosis, dermatopathology and treatment. Semin Dermatol 1991, 10:282-292.
36. Reuler J., Broudy V., Cooney T. Adult scurvy. JAMA 1985, 253:805-807.
37. West B., Anderson P. Alcohol and acquired acrodermatitis enteropathica. J Am Acad Dermatol 1986, 15:1305. [letter].
38. Delahoussaye A., Jorizzo J. Cutaneous manifestations of nutritional disorders. Dermatol Clin 1989, 7:559-569.
39. Smith K., Fenske N. Cutaneous manifestations of alcohol abuse. J Am Acad Dermatol 2000, 43:1-18.
40. Girard D., Kumar K., McAfee J. Hematological effects of acute and chronic alcohol abuse. Hematol Oncol Clin North Am 1987, 1:321-329.
41. Mehregan D., Su W., Anhalt J. Cutaneous botryomycosis. J Am Acad Dermatol 1991, 24:393-396.
42. Harnisch J., Tronca E., Nolan C., et al. Diphtheria among alcoholic urban adults. Ann Intern Med 1989, 111:71-82.
43. Higgins E., du Vivier A. Alcohol and the skin. Alcohol Alcohol 1992, 27:595-602.
44. Hughes P., Apisamthanarax P., Mullins J. Subcutaneous fat necrosis associated with pancreatic disease. Arch Dermatol 1975, 111:506-510.
45. Muhlbauer J., Pathak M. Porphyria cutanea tarda. Int J Dermatol 1979, 18:767-780.
46. Grossman M., Bickers D., Poh-Fitzpatrick M., et al. Porphyria cutanea tarda. Am J Med 1979, 67:277-286.
47. Ghosn S., Kibbi A. Cutaneous manifestations of liver disease. Clin Dermatol 2008, 26:274-282.
48. Berman J., Lankin B. Hepatic disease and the skin. Dermatol Clin 1989, 7:435-448.
49. Adjarov D., Naydenova E., Ivanov E., et al. Choice of therapy in porphyria cutanea tarda. Clin Exp Dermatol 1996, 21:461-468.
50. Scholnick P.L., Epstein J., Marver H.S. The molecular basis of the action of chloroquine in porphyria cutanea tarda. J Invest Dermatol 1971, 61:226-232.
51. Shieh S., Cohen J.L., Lim H.W. Management of porphyria cutanea tarda in the setting of chronic renal failure: a case report and review. J Am Acad Dermatol 2000, 42:645-652.
52. Gupta M., Schork N., Gupta A., et al. Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J Am Acad Dermatol 1993, 28:730-732.
53. Farber E., Nall L. Psoriasis and alcoholism. Cutis 1994, 53:21-27.
54. Karvonen J., Poikolainen K., Reunala T., et al. Alcohol and smoking: risk factors for infectious eczematoid dermatitis?. Acta Derm Venereol (Stockl) 1992, 72:208-210.
55. Substance Abuse and Mental Health Services Administration (SAMHSA) Results from the 2006 National Survey on Drug Use and Health: national findings 2007, Office of Applied Studies, Washington, DC.
56. Durell T.M., Kroutil L.A., Crits-Christoph P. Prevalence of nonmedical methamphetamine use in the United States. Subst Abuse Treat Prev Policy 2008, 3:19.
57. Office of National Drug Control Policy (ONDCP) Synthetic drug control strategy: a focus on methamphetamine and prescription drug abuse (Annual ONDCP Report) 2006, Office of National Drug Control Policy, Washington, DC.
58. Lambert D., Gale J.A., Hartley D. Substance abuse by youth and young adults in rural america. J Rural Health 2008, 24:221-228.
59. Gfroerer J.C., Larson S.L., Colliver J.D. Drug use patterns and trends in rural communities. J Rural Health 2007, 23S:10-15.
60. Lineberry T.W., Bostwick J.M. Methamphetamine abuse: a perfect storm of complications. Mayo Clin Proc 2006, 81:77-84.
61. Substance Abuse and Mental Health Services Administration (SAMHSA) National survey on drug use and health (1994-2004) 2005, Office of Applied Studies, Rockville (Md).
62. Darke S., Ross J., Kaye S. Physical injecting sites among injecting drug users in Sydney, Australia. Drug Alcohol Depend 2001, 62:77-82.
63. Horowitz H.W. Learning to recognize scarring among drug users: a tool for HIV risk reduction. Am J Public Health 1997, 87:1233-1234.
64. Trimarchi M., Nicolai P., Lombardi D., et al. Sinonasal osteocartilaginous necrosis in cocaine abusers: experience in 25 patients. Am J Rhinol 2003, 17:33-43.
65. Posner D., Guill M. Cutaneous foreign body granulomas associated with intravenous drug use. J Am Acad Dermatol 1985, 13:869-872.
66. Blumstein H., Roberts J. Retained needle fragments and digital dissection. N Engl J Med 1993, 328:1426.
67. Smith D., Bosuito M., Velanowitch V., et al. Drug injection injuries of the upper extremity. Ann Plast Surg 1989, 22:19-24.
68. Fellner M., Ledesma G. Leg ulcers secondary to drug reactions. Clin Dermatol 1990, 8:144-149.
69. Brewer J., Meves A., Bostwick M., et al. Cocaine abuse: dermatologic manifestations and therapeutic approaches. J Am Acad Dermatol 2008, 59:483-487.
70. Weidman A., Fellner M. Cutaneous manifestations of heroin and other addictive drugs. N Y State J Med 1971, 71:2643-2646.
71. Frieden J. Skin may signal crystal meth use. Skin Allergy News 2006, Available at: http://findarticles.com/p/articles/mi_hb4393/is_1_37/ai_n29281552/36:47. Accessed Nov 17, 09.
72. Yaffee H. Cutaneous stimas associated with methedrine (methamphetamine). Arch Derm 1971, 104:637.
73. Stone M.H., Stone D.H., MacGregor H. Anatomical distribution of soft tissue sepsis sites in intravenous drug misusers attending an accident and emergency department. Br J Addiction 1990, 85:1495-1496.
74. Vollum D.I. Skin lesions in drug addicts. Br Med J 1970, 2:64-65.
75. Salgado C.D., Farr B.M., Calfee D.P. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003, 36:131-139.
76. Bergstein J.M., Baker E.J., Aprahamian C., et al. Soft tissue abscesses associated with parenteral drug abuse: presentation, microbiology and treatment. Am Surg 1995, 61:1105-1108.
77. Webb D., Thadepalli H. Skin and soft tissue polymicrobial infections from intravenous infections from intravenous abuse of drugs. West J Med 1979, 130:200-204.
78. Talan D.A., Summanen P.H., Finegold S.M. Ampicillin sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse. Clin Infect Dis 2000, 31:434-471.
79. Summanen P.H., Talan D.A., Strong C., et al. Bacteriology of skin and soft-tissue infections: comparisons of infections in intravenous drug users and individuals with no history of intravenous drug use. Clin Infect Dis 1995, 20:S279-S282.
80. Bosshardt T.L., Henderson V.H., Organ C.H. Necrotizing soft-tissue infections. Arch Surg 1996, 131:846-854.
81. Chen J.L., Fullerton K.E., Flyn N.M. Necrotizing fasciitis associated with injection drug use. Clin Infect Dis 2001, 33:6-15.
82. Callahan E.I., Schecter W.P., Horn J.K. Necrotizing soft tissue infection masquerading as cutaneous abscess following illicit drug injection. Arch Surg 1998, 133:812-817.
83. Donovan C., McEwan R. A review of the literature examining the relationship between alcohol use and HIV-related sexual risk-taking in your people. Addiction 1995, 90:319-328.
84. Hapern-Felsher B.L., Millstein S.G., Ellen J.M. Relationship of alcohol use and risky sexual behavior: a review and analysis of findings. J Adolesc Health 1996, 19:331-336.
85. Bickley L.K., Schwartz R.A., Lambert W.C. Localized cutaneous leukocytoclastic vasculitis in an intravenous drug abuser. Int J Dermatol 1988, 27:512-513.
86. deCuyper C., Goeteyn M. Systemic contact dermatitis from subcutaneous hydromorphone. Contact Dermatitis 1992, 27:220-223.
87. Shaner J.W. Caries associated with methamphetamine abuse. J Mich Dent Assoc 2002, 84:42-47.
88. Morio K.A., Marshall T.A., Qian F., et al. Comparing diet, oral hygiene and caries status of adult methamphetamine users and nonusers: a pilot study. J Am Dent Assoc 2008, 139:171-176.
89. Hamamoto D.T., Rhodus N.L. Methamphetamine abuse and dentistry. Oral Dis 2009, 15:27-37.